CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 90 enrolled
Drug / intervention
5mg Oxycodone, Q6 PRN +1 moredrug
Likely dose
5mg Oxycodone, Q6 PRNfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05924165
NCT05924165Phase 4Completed
CompareCT.gov

Narcotic-Free Percutaneous Nephrolithotomy

Icahn School of Medicine at Mount Sinai·interventional·Posted Jun 29, 2023·Updated Mar 26, 2025

In Brief

A Phase 4 clinical trial evaluating 5mg Oxycodone, Q6 PRN and 10mg Ketorolac, Q6 PRN for Nephrolithiasis. Completed, enrolled 90 participants across 1 site.

Detailed Summary

This is a randomized control trial comparing oral ketorolac and opioid medication for the use of post-operative analgesia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNephrolithiasis
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
202420252026
First PostedJun 29, 2023
Enrollment StartMay 19, 2023
Primary CompletionJan 7, 2025
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 3.0 years ago

Interventions

5mg Oxycodone, Q6 PRNdrug

Oxycodone is an opioid that is used to relieve moderate to severe pain.

10mg Ketorolac, Q6 PRNdrug

Ketorolac is an NSAID used to relieve moderately severe pain.